Magenta Therapeutics, Inc.·4

Jun 15, 4:33 PM ET

Beetham Thomas W. 4

4 · Magenta Therapeutics, Inc. · Filed Jun 15, 2021

Insider Transaction Report

Form 4
Period: 2021-06-14
Transactions
  • Award

    Stock Option (Right to Buy)

    2021-06-14+200,000200,000 total
    Exercise: $11.37Exp: 2031-06-13Common Stock (200,000 underlying)
Footnotes (1)
  • [F1]This option shall vest and become exerciseable over four years, with 25% of this option vesting on June 14, 2022, and the remainder vesting in 36 equal monthly installments thereafter.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION